mitophagy therapeutic platform development

Capacity Bio, Inc. is a private, mitochondria-focused biotechnology company developing a first-in-class mitophagy therapeutic platform along with an analytical toolkit to characterize mitochondria. Its proprietary approach develops small molecules, peptides, and nanoparticles that enhance identification of dysfunctional mitochondria, activate mitophagy pathways, and promote clearance by autophagosomes and lysosomes.

Read more

mitochondrial characterizationpreclinical programs